These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3468909)
1. Reduction of gentamicin nephrotoxicity by the concomitant administration of poly-l-aspartic acid and poly-l-asparagine in rats. Beauchamp D; Laurent G; Maldague P; Tulkens PM Arch Toxicol Suppl; 1986; 9():306-9. PubMed ID: 3468909 [TBL] [Abstract][Full Text] [Related]
2. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids. Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro. Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355 [TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats. Kishore BK; Ibrahim S; Lambricht P; Laurent G; Maldague P; Tulkens PM J Pharmacol Exp Ther; 1992 Jul; 262(1):424-32. PubMed ID: 1378098 [TBL] [Abstract][Full Text] [Related]
6. Calcium supplementation and thyroid hormone protect against gentamicin-induced inhibition of proximal tubular Na+,K(+)-ATPase activity and other renal functional changes. Fukuda Y; Eklöf AC; Malmborg AS; Aperia A Acta Physiol Scand; 1992 Jun; 145(2):93-8. PubMed ID: 1322021 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of gentamicin nephrotoxicity in rats and the protective effect of zinc-induced metallothionein synthesis. Du XH; Yang CL Nephrol Dial Transplant; 1994; 9 Suppl 4():135-40. PubMed ID: 7800247 [TBL] [Abstract][Full Text] [Related]
8. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Giuliano RA; Paulus GJ; Verpooten GA; Pattyn VM; Pollet DE; Nouwen EJ; Laurent G; Carlier MB; Maldague P; Tulkens PM Kidney Int; 1984 Dec; 26(6):838-47. PubMed ID: 6533395 [TBL] [Abstract][Full Text] [Related]
9. Influence of hydrocortisone on gentamicin-induced nephrotoxicity in rats. Beauchamp D; Pettigrew M Antimicrob Agents Chemother; 1988 Jul; 32(7):992-6. PubMed ID: 3190200 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin. Morin NJ; Frau A; Nonclercq D; Toubeau G; Zanen J; Heuson-Stiennon JA; Bergeron MG; Beauchamp D; Laurent G Exp Mol Pathol; 1994 Jun; 60(3):197-213. PubMed ID: 7525340 [TBL] [Abstract][Full Text] [Related]
12. Co-oxydextran as a protectant against gentamicin-induced renal lysosomal phospholipidosis and focal tubular necrosis. Perspectives and limitations. Kishore BK; Van Schepdael A; Laurent G; Lambricht P; Claes PJ; Piret J; Tulkens PM; Maldague P Contrib Nephrol; 1993; 101():213-9. PubMed ID: 7682169 [No Abstract] [Full Text] [Related]
13. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Erdem A; Gündoğan NU; Usubütün A; Kilinç K; Erdem SR; Kara A; Bozkurt A Nephrol Dial Transplant; 2000 Aug; 15(8):1175-82. PubMed ID: 10910441 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463 [TBL] [Abstract][Full Text] [Related]
15. Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study. Nonclercq D; Wrona S; Toubeau G; Zanen J; Heuson-Stiennon JA; Schaudies RP; Laurent G Ren Fail; 1992; 14(4):507-21. PubMed ID: 1462002 [TBL] [Abstract][Full Text] [Related]
16. Features of gentamicin nephrotoxicity and effect of concurrent cephalothin in the rat. Sugarman A; Brown RS; Silva P; Rosen S Nephron; 1983; 34(4):239-47. PubMed ID: 6877460 [TBL] [Abstract][Full Text] [Related]
17. Inability of nitrendipine to protect against gentamicin nephrotoxicity in the rat. Kacew S Biomed Environ Sci; 1989 Jun; 2(2):160-6. PubMed ID: 2556158 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides. Williams PD; Hottendorf GH; Bennett DB J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895 [TBL] [Abstract][Full Text] [Related]
19. A 2'guanidyl derivative of gentamicin (S86451) with reduced nephrotoxicity studies at low and medium dose levels in the rat. Maldague P; Laurent G; Carlier MB; Tulkens P Arch Toxicol Suppl; 1984; 7():455-8. PubMed ID: 6596014 [TBL] [Abstract][Full Text] [Related]
20. Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat. Ramsammy LS; Josepovitz C; Ling KY; Lane BP; Kaloyanides GJ Biochem Pharmacol; 1987 Jul; 36(13):2125-32. PubMed ID: 3111476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]